We are live on ! Find out more
Aster Capital Management

Aster Capital Management Portfolio holdings

AUM $275M Turnover 72.56%
1-Year Est. Return 18.46%
This Fund
S&P 500
This Quarter Est. Return
-1.47%
1 Year Est. Return
+18.46%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$275M
AUM Growth
-$195M
Cap. Flow
-$180M
Cap. Flow %
-65.37%
Top 10 Hldgs %
10.94%
Holding
1,392
New
584
Increased
169
Reduced
213
Closed
426
Avg Time Held
0.2 years
Top 10 Avg Time Held
0 years
Top 20 Avg Time Held
0 years

Top Buys

Rank Stock Value
1
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$4.57M
2
OVV icon
Ovintiv
OVV
+$3.99M
3
KIM icon
Kimco Realty
KIM
+$3.52M
4
ALAB icon
Astera Labs
ALAB
+$3.33M
5
HUT icon
Hut 8
HUT
+$2.16M

Top Sells

Rank Stock Value
1
IYR icon
iShares US Real Estate ETF
IYR
+$11.3M
2
AAPL icon
Apple
AAPL
+$7.75M
3
MSFT icon
Microsoft
MSFT
+$6.82M
4
HON icon
Honeywell
HON
+$6.34M
5
KO icon
Coca-Cola
KO
+$5.38M

Sector Composition

Rank Sector Weight
1 Financials 16.08%
2 Technology 15.72%
3 Industrials 13.9%
4 Healthcare 13.43%
5 Consumer Discretionary 10.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
CGEM icon
851
Cullinan Therapeutics
CGEM
$589M
$4.67K ﹤0.01%
+304
New +$5.82K
2026 Q3
0 quarters
WABC icon
852
Westamerica Bancorp
WABC
$1.34B
$4.67K ﹤0.01%
80
+34
+74% +$2.02K
2026 Q2
1 quarter
SENEA icon
853
Seneca Foods Class A
SENEA
$1.17B
$4.63K ﹤0.01%
+130
New +$4.73K
2026 Q3
0 quarters
CNMD icon
854
CONMED
CNMD
$1.38B
$4.62K ﹤0.01%
+100
New +$4.58K
2026 Q3
0 quarters
LKFN icon
855
Lakeland Financial
LKFN
$1.48B
$4.61K ﹤0.01%
80
+24
+43% +$1.46K
2026 Q2
1 quarter
JBIO icon
856
Jade Biosciences
JBIO
$1.04B
$4.61K ﹤0.01%
328
-848
-72% -$17K
2026 Q2
1 quarter
SBSI icon
857
Southside Bancshares
SBSI
$982M
$4.6K ﹤0.01%
153
+61
+66% +$1.99K
2026 Q2
1 quarter
SPFI icon
858
South Plains Financial
SPFI
$774M
$4.55K ﹤0.01%
+109
New +$4.8K
2026 Q3
0 quarters
BBSI icon
859
Barrett Business Services
BBSI
$721M
$4.54K ﹤0.01%
+150
New +$5.3K
2026 Q3
0 quarters
MMSI icon
860
Merit Medical Systems
MMSI
$5.06B
$4.4K ﹤0.01%
+51
New +$4.27K
2026 Q3
0 quarters
GGB icon
861
Gerdau
GGB
$8.51B
$4.23K ﹤0.01%
+897
New +$4.26K
2026 Q3
0 quarters
LIVN icon
862
LivaNova
LIVN
$5.07B
$4.13K ﹤0.01%
+54
New +$4.31K
2026 Q3
0 quarters
DAN icon
863
Dana Inc
DAN
$2.32B
$4.02K ﹤0.01%
+147
New +$4.22K
2026 Q3
0 quarters
UE icon
864
Urban Edge Properties
UE
$2.6B
$4K ﹤0.01%
+205
New +$4.45K
2026 Q3
0 quarters
SKY icon
865
Champion Homes
SKY
$4.91B
$3.94K ﹤0.01%
+46
New +$3.96K
2026 Q3
0 quarters
MT icon
866
ArcelorMittal
MT
$44.5B
$3.94K ﹤0.01%
+59
New +$4.18K
2026 Q3
0 quarters
RYZ icon
867
Ryerson Holding
RYZ
$1.44B
$3.91K ﹤0.01%
166
+163
+5,433% +$4.32K
2026 Q2
1 quarter
PNTG icon
868
Pennant Group
PNTG
$1.2B
$3.86K ﹤0.01%
99
+70
+241% +$2.77K
2026 Q2
1 quarter
OLLI icon
869
Ollie's Bargain Outlet
OLLI
$5.61B
$3.85K ﹤0.01%
45
-864
-95% -$63.9K
2026 Q1
2 quarters
TDOC icon
870
Teladoc Health
TDOC
$1.42B
$3.8K ﹤0.01%
+655
New +$4.79K
2026 Q3
0 quarters
ARHS icon
871
Arhaus
ARHS
$1.83B
$3.72K ﹤0.01%
393
-1,173
-75% -$10K
2026 Q2
1 quarter
DOLE icon
872
Dole
DOLE
$1.17B
$3.43K ﹤0.01%
+270
New +$3.69K
2026 Q3
0 quarters
CPK icon
873
Chesapeake Utilities
CPK
$3.44B
$3.34K ﹤0.01%
+26
New +$3.43K
2026 Q3
0 quarters
HMN icon
874
Horace Mann Educators
HMN
$2.13B
$3.3K ﹤0.01%
+74
New +$3.76K
2026 Q3
0 quarters
BTSG icon
875
BrightSpring Health Services
BTSG
$12.7B
$3.24K ﹤0.01%
+57
New +$3.59K
2026 Q3
0 quarters

Similar funds

Aster Capital Management's Q3 2026 Portfolio in Review

As of Q3 2026, Aster Capital Management held 1,392 positions worth $275M, down 41% from $470M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Aster Capital Management withdrew a net $180M in Q3 2026, closing 426 positions and reducing 213 holdings. Its most notable exit was iShares US Real Estate ETF, an estimated $11.3M position sold in full.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 11% a quarter earlier, followed by Technology and Industrials.

Against the trend, Aster Capital Management opened a new position in Alnylam Pharmaceuticals worth $4.43M.

  • Aster Capital Management's largest Q3 2026 buy was Alnylam Pharmaceuticals: 17,949 shares worth $4.43M.
  • Aster Capital Management added most to Simon Property Group in Q3 2026, an estimated $1.93M increase.
  • Aster Capital Management's biggest Q3 2026 reduction was Meta Platforms (Facebook), cutting an estimated $4.29M.
  • Aster Capital Management fully exited iShares US Real Estate ETF in Q3 2026, selling an estimated $11.3M.
  • Aster Capital Management's ten largest holdings make up 11% of its $275M portfolio in Q3 2026.
  • Aster Capital Management opened 584 new positions and closed 426 in Q3 2026.
  • Aster Capital Management's portfolio value fell 41% quarter-over-quarter to $275M.

Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.